Doctor-guided, personalized treatment plans.

A daily GLP-1 injection, prescribed and personalized to support weight loss.

Metformin supports metabolic health by enhancing insulin sensitivity and reducing glucose production in the liver. Commonly used to manage insulin resistance, PCOS, and prediabetes, it may also support weight regulation and overall metabolic balance.

FDA-approved for the treatment of type 2 diabetes and improved glycemic control.

Ozempic is a weekly injectable medication designed to help adults with type 2 diabetes manage blood sugar levels. It also supports weight loss by reducing appetite and slowing digestion. The active ingredient, semaglutide, is a GLP-1 receptor agonist that mimics a natural hormone in the body.

FDA-approved for weight management for patients with obesity or overweight and related conditions.

Wegovy is a weekly injectable medication that helps adults with obesity or weight-related conditions lose and manage weight. The active ingredient, semaglutide, is a GLP-1 receptor agonist that works by reducing appetite and increasing feelings of fullness.

FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Mounjaro is a weekly injection that contains tirzepatide, a dual GIP and GLP-1 receptor agonist. It is approved for type 2 diabetes and works by activating both receptors to reduce appetite and support weight loss.

FDA-approved for weight management in adults with obesity or overweight and related conditions.

Zepbound is a weekly injectable medication that contains tirzepatide, a dual GIP and GLP-1 receptor agonist. It works by reducing appetite, increasing feelings of fullness, and supporting long-term weight loss when used with lifestyle changes.